These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33081816)

  • 21. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.
    Chan PH; Hai JJ; Chan EW; Li WH; Tse HF; Wong IC; Lip GY; Siu CW
    PLoS One; 2016; 11(3):e0150674. PubMed ID: 27010633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life (QoL) and International Normalized Ratio (INR) control of patients attending anticoagulation clinics.
    Hasan SS; Teh KM; Ahmed SI; Chong DW; Ong HC; Naina B
    Public Health; 2015 Jul; 129(7):954-62. PubMed ID: 26138018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K
    PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin].
    Ohgushi A; Nakayama N; Namiki A; Nagashima A; Ogawa R; Akazawa M; Echizen H
    Yakugaku Zasshi; 2019; 139(9):1177-1183. PubMed ID: 31474634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-Reported Treatment Satisfaction with Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation in China.
    Geng YP; Lan DH; Liu N; Du X; Zheng D; Tang RB; Long DY; Yu RH; Sang CH; Bai R; Jiang CX; Li SN; Guo XY; Wang W; Xia SJ; Chang SS; Dong JZ; Chen AH; Ma CS
    Thromb Haemost; 2018 Oct; 118(10):1815-1822. PubMed ID: 30235486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R; Figueroa Guerrero CA; Mainar de Paz V; Arribas García MP; Sánchez Perruca L; Rodríguez Barrientos R; Casado López M; Pedraza Flechas AM
    Med Clin (Barc); 2015 Sep; 145(5):192-7. PubMed ID: 25433789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status.
    Varona JF; Seguí-Ripoll JM; Lozano-Duran C; Cuadrado-Gómez LM; Montagud-Moncho JB; Ramos-Guerrero A; Mirete-Ferrer JC; Donado E; García-Alegría J;
    Health Qual Life Outcomes; 2020 Dec; 18(1):383. PubMed ID: 33308246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry.
    Liang HF; Du X; Zhou YC; Yang XY; Xia SJ; Dong JZ; Lip GYH; Ma CS
    Med Sci Monit; 2019 Jun; 25():4691-4698. PubMed ID: 31232394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation.
    Liu S; Li X; Shi Q; Hamilton M; Friend K; Zhao Y; Horblyuk R; Hede S; Shi L
    Curr Med Res Opin; 2018 Mar; 34(3):415-421. PubMed ID: 28945114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing warfarin control in Australia and Singapore.
    Bernaitis N; Ching CK; Teo SC; Chen L; Badrick T; Davey AK; Crilly J; Anoopkumar-Dukie S
    Thromb Res; 2017 Sep; 157():120-125. PubMed ID: 28738273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Warfarin Anticoagulation in Indigenous and Non-Indigenous Australians With Atrial Fibrillation.
    Nguyen MT; Gallagher C; Pitman BM; Emami M; Kadhim K; Hendriks JM; Middeldorp ME; Roberts-Thomson KC; Mahajan R; Lau DH; Sanders P; Wong CX
    Heart Lung Circ; 2020 Aug; 29(8):1122-1128. PubMed ID: 31980393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
    Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.
    Maeder MT; König T; Bogdanovic S; Schneider I; Eugster W; Ammann P; König M; Beer J; Rickli H
    Swiss Med Wkly; 2017; 147():w14503. PubMed ID: 29039622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warfarin control in Hong Kong clinical practice: a single-centre observational study.
    Lam ASM; Lee IMH; Mak SKS; Yan BPY; Lee VWY
    Hong Kong Med J; 2020 Aug; 26(4):294-303. PubMed ID: 32729553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey.
    Gattellari M; Worthington JM; Zwar NA; Middleton S
    BMC Fam Pract; 2008 Nov; 9():62. PubMed ID: 19014560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of anticoagulation with warfarin across Kuwait.
    Zubaid M; Saad H; Ridha M; Mohanan Nair KK; Rashed W; Alhamdan R; Alenezi F; Maghami M; Sadek A
    Hellenic J Cardiol; 2013; 54(2):102-6. PubMed ID: 23557609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study.
    Silva PGMBE; Sznejder H; Vasconcellos R; Charles GM; Mendonca-Filho HTF; Mardekian J; Nascimento R; Dukacz S; Fusco MD
    Arq Bras Cardiol; 2020 Mar; 114(3):457-466. PubMed ID: 32049154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study.
    Koretsune Y; Kumagai K; Uchiyama S; Yamashita T; Yasaka M; Watanabe-Fujinuma E; Banderas BF; Akiyama S; Okayama Y; Briere JB; Dickie G; Cano SJ
    Curr Med Res Opin; 2018 Dec; 34(12):2157-2164. PubMed ID: 30067119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Dysfunction Affects Anticoagulation Control With Warfarin and Outcomes in Japanese Elderly Patients With Non-Valvular Atrial Fibrillation.
    Inoue H; Kodani E; Atarashi H; Okumura K; Yamashita T; Origasa H;
    Circ J; 2018 Aug; 82(9):2277-2283. PubMed ID: 29984788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.